MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-26-2026
DENTSPLY SIRONA Cash and Cash Equivalents 2011-2026 | XRAY
Annual Cash and Cash Equivalents DENTSPLY SIRONA
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 326 M | 272 M | 334 M | 365 M | 339 M | 438 M | 405 M | 310 M | 321 M | 384 M | 285 M | 152 M | 75 M | 80.1 M | 77.1 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 438 M | 75 M | 277 M |
Quarterly Cash and Cash Equivalents DENTSPLY SIRONA
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 363 M | 359 M | 398 M | 272 M | 296 M | 279 M | 291 M | 334 M | 309 M | 295 M | 318 M | 365 M | 418 M | 362 M | 374 M | 339 M | 281 M | 332 M | 339 M | 438 M | 438 M | 438 M | 438 M | 405 M | 405 M | 405 M | 405 M | 310 M | 310 M | 310 M | 310 M | 321 M | 321 M | 321 M | 321 M | 384 M | 384 M | 384 M | 384 M | 285 M | 285 M | 285 M | 285 M | 152 M | 152 M | 152 M | 152 M | 75 M | 75 M | 75 M | 75 M | 80.1 M | 80.1 M | 80.1 M | 80.1 M | 77.1 M | 77.1 M | 77.1 M | 77.1 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 438 M | 75 M | 278 M |
Cash and Cash Equivalents of other stocks in the Medical instruments industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
3.56 M | - | - | $ 810 M |  USA |
 |
Alcon
ALC
|
1.53 B | $ 75.4 | -0.8 % | $ 40.4 B |  Schweiz |
 |
Ekso Bionics Holdings
EKSO
|
1.17 M | $ 11.21 | -1.41 % | $ 27.2 M | USA |
 |
The Cooper Companies
COO
|
111 M | $ 63.09 | -1.94 % | $ 12.6 B | USA |
 |
ICU Medical
ICUI
|
308 M | $ 121.01 | -1.5 % | $ 2.98 B | USA |
 |
iRhythm Technologies
IRTC
|
236 M | $ 125.44 | -0.41 % | $ 4.01 B | USA |
 |
Haemonetics Corporation
HAE
|
307 M | $ 59.84 | -1.06 % | $ 3.01 B | USA |
 |
electroCore
ECOR
|
7.04 M | $ 6.15 | 1.32 % | $ 52.2 K | USA |
 |
Repro Med Systems
KRMD
|
8.87 M | $ 4.08 | 0.49 % | $ 188 M | USA |
 |
Isoray
ISR
|
30.6 M | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
3.37 B | $ 466.64 | -0.92 % | $ 167 B | USA |
 |
Microbot Medical
MBOT
|
3.91 M | $ 2.1 | -3.23 % | $ 96.2 M |  Israel |
 |
Glaukos Corporation
GKOS
|
93.5 M | $ 119.63 | -2.0 % | $ 5.79 B | USA |
 |
Milestone Scientific
MLSS
|
1.11 M | $ 0.33 | -4.15 % | $ 27.1 M | USA |
 |
Masimo Corporation
MASI
|
178 M | $ 178.51 | -0.08 % | $ 9.51 B | USA |
 |
InfuSystem Holdings
INFU
|
165 K | $ 10.18 | -4.5 % | $ 210 M | USA |
 |
Merit Medical Systems
MMSI
|
446 M | $ 66.74 | -1.02 % | $ 3.95 B | USA |
 |
Envista Holdings Corporation
NVST
|
1.21 B | $ 26.49 | -1.05 % | $ 4.45 B | USA |
 |
Pulse Biosciences
PLSE
|
80.7 M | $ 21.83 | -3.62 % | $ 1.47 B | USA |
 |
Retractable Technologies
RVP
|
2.59 M | $ 0.62 | -2.99 % | $ 18.6 M | USA |
 |
Pro-Dex
PDEX
|
419 K | $ 51.51 | -0.87 % | $ 169 M | USA |
 |
LeMaitre Vascular
LMAT
|
28.2 M | $ 112.4 | -1.85 % | $ 2.54 B | USA |
 |
STAAR Surgical Company
STAA
|
153 M | $ 26.7 | 0.07 % | $ 1.32 B | USA |
 |
STERIS plc
STE
|
172 M | $ 219.75 | -1.1 % | $ 21.7 B | USA |
 |
Predictive Oncology
POAI
|
10.8 M | - | - | $ 31.1 M | USA |
 |
Teleflex Incorporated
TFX
|
379 M | $ 135.52 | 0.33 % | $ 6.05 B | USA |
 |
BioLife Solutions
BLFS
|
95.4 M | $ 20.9 | -2.38 % | $ 963 M | USA |
 |
Stereotaxis
STXS
|
13.4 M | $ 1.86 | -3.63 % | $ 169 M | USA |
 |
Baxter International
BAX
|
1.97 B | $ 17.94 | -2.97 % | $ 9.2 B | USA |
 |
ResMed
RMD
|
274 M | $ 217.14 | -2.2 % | $ 31.7 B | USA |
 |
AtriCure
ATRC
|
167 M | $ 28.48 | -1.93 % | $ 1.36 B | USA |
 |
Utah Medical Products
UTMD
|
85.8 M | $ 66.61 | -0.25 % | $ 216 M | USA |
 |
Harvard Bioscience
HBIO
|
8.61 M | $ 6.45 | -5.56 % | $ 286 M | USA |
 |
NeuroMetrix
NURO
|
1.43 M | - | 5.05 % | $ 9.02 M | USA |
 |
West Pharmaceutical Services
WST
|
791 M | $ 292.13 | -3.33 % | $ 21.1 B | USA |
 |
AngioDynamics
ANGO
|
55.9 M | $ 10.98 | -0.99 % | $ 449 M | USA |
 |
Becton, Dickinson and Company
BDX
|
641 M | $ 149.52 | -0.47 % | $ 43 B | USA |
 |
Nephros
NEPH
|
4.31 M | $ 3.32 | 2.79 % | $ 34.5 M | USA |
 |
OraSure Technologies
OSUR
|
199 M | $ 3.01 | - | $ 221 M | USA |
 |
Repligen Corporation
RGEN
|
751 M | $ 117.43 | -0.73 % | $ 6.54 M | USA |